Keith Hoffman, PhD

Keith Hoffman, PhD has extensive experience in the biotech and health informatics industries. From 2010 to 2016, they served as Vice President at Advera Health Analytics, where they focused on improving patient safety and reducing healthcare costs through the analysis of real-world outcomes data.

In 2016, Keith joined The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center as the Senior Vice President of Business Development and Technology Transfer. During their tenure, they played a key role in translating research into commercial applications, resulting in numerous global medical breakthroughs and the creation of several start-up companies.

Since November 2020, Keith has been working as the Chief Business Officer at Athos Therapeutics Inc, a late-stage preclinical biotech company. Here, they lead the identification of novel drug targets using an innovative artificial intelligence process that integrates clinical and molecular datasets into disease interactomes. This process is matched to the company's small molecule computational chemistry platform for the development of small molecule therapeutics for autoimmune diseases.

Overall, Keith Hoffman, PhD has demonstrated expertise in business development, technology transfer, and the application of data analytics in the healthcare industry.

Keith Hoffman, PhD, obtained their Bachelor of Science (BS) degree in Biology/Biological Sciences, General from UC Irvine, where they studied from 1990 to 1994. Following this, they pursued further education at UC Irvine and completed their Doctor of Philosophy (PhD) in Neuropharmacology from 1994 to 1997.